Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment

Biomarkers

Volumn 17, Issue 7, 2012, Pages 663-667

  Kefeli, Umut ^a   Yildirim, Mahmut Emre ^a   Aydin, Dincer ^a   Madenci, Ozlem Cakir ^a   Yasar, Nurgul ^a   Sener, Nur ^a   Mert, Aslihan Guven ^a   Yuksel, Sinemis ^a   Ercelep, Ozlem Balvan ^a   Korkmaz, Taner ^a   Yildiz, Ramazan ^a   Gumus, Mahmut ^a  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Gastric cancer; Netrin 1; Treatment

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; NETRIN 1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84867923166     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2012.709882     Document Type: Article

References (29)

1. Arakawa H. (2004). Netrin-1 and its receptors in tumorigenesis. Nat Rev Cancer 4:978-987.
2. Bernet A, Mazelin L, Coissieux MM, Gadot N, Ackerman SL, Scoazec JY, Mehlen P. (2007). Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology 133:1840-1848.
3. Chen JM, Wang SH, Xu SX, Han BS. (2011). [Netrin-1 protein expression in gastric cancer and its correlation with clinicopathologic features and prognosis]. Sichuan Da Xue Xue Bao Yi Xue Ban 42:802-806.
4. Delloye-Bourgeois C, Fitamant J, Paradisi A, Cappellen D, Douc-Rasy S, Raquin MA, Stupack D, Nakagawara A, Rousseau R, Combaret V, Puisieux A, Valteau-Couanet D, Bénard J, Bernet A, Mehlen P. (2009). Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med 206:833-847.
5. Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A. (2009). Interference with netrin-1 and tumor cell death in nonsmall cell lung cancer. J Natl Cancer Inst 101:237-247.
6. Dumartin L, Quemener C, Laklai H, Herbert J, Bicknell R, Bousquet C, Pyronnet S, Castronovo V, Schilling MK, Bikfalvi A, Hagedorn M. (2010). Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. Gastroenterology 138:1595-606, 1606.e1.
7. Fitamant J, Guenebeaud C, Coissieux MM, Guix C, Treilleux I, Scoazec JY, Bachelot T, Bernet A, Mehlen P. (2008). Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. Proc Natl Acad Sci USA 105:4850-4855.
8. Goldschneider D, Mehlen P. (2010). Dependence receptors: A new paradigm in cell signaling and cancer therapy. Oncogene 29:1865-1882.
9. Greene FLPD, Fleming ID. (2002). American joint committee on cancer staging manual. 6th edition. Philadelphia: Springer.\
10. Hibi K, Sakata M, Sakuraba K, Kitamura YH, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. (2009). Changes in UNC5C gene methylation during human gastric carcinogenesis. Anticancer Res 29:4397-4399.
11. Hibi K, Sakata M, Sakuraba K, Kitamura YH, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y. (2010). Methylation of the DCC gene is lost in advanced gastric cancer. Anticancer Res 30:107-109.
12. Kaufmann S, Kuphal S, Schubert T, Bosserhoff AK. (2009). Functional implication of Netrin expression in malignant melanoma. Cell Oncol 31:415-422.
13. Latil A, Chêne L, Cochant-Priollet B, Mangin P, Fournier G, Berthon P, Cussenot O. (2003). Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 103:306-315.
14. Llambi F, Causeret F, Bloch-Gallego E, Mehlen P. (2001). Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 20:2715-2722.
15. Llambi F, Lourenço FC, Gozuacik D, Guix C, Pays L, Del Rio G, Kimchi A, Mehlen P. (2005). The dependence receptor UNC5H2 mediates apoptosis through DAP-kinase. EMBO J 24:1192-1201.
16. Ly NP, Komatsuzaki K, Fraser IP, Tseng AA, Prodhan P, Moore KJ, Kinane TB. (2005). Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci USA 102:14729-14734.
17. Mehlen P, Furne C. (2005). Netrin-1: When a neuronal guidance cue turns out to be a regulator of tumorigenesis. Cell Mol Life Sci 62:2599-2616.
18. Mehlen P, Guenebeaud C. (2010). Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol 22:46-54.
19. Mehlen P, Delloye-Bourgeois C, Chédotal A. (2011). Novel roles for Slits and netrins: Axon guidance cues as anticancer targets? Nat Rev Cancer 11:188-197.
20. Meyerhardt JA, Caca K, Eckstrand BC, Hu G, Lengauer C, Banavali S, Look AT, Fearon ER. (1999). Netrin-1: Interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas. Cell Growth Differ 10:35-42.
21. Mirakaj V, Thix CA, Laucher S, Mielke C, Morote-Garcia JC, Schmit MA, Henes J, Unertl KE, Köhler D, Rosenberger P. (2010). Netrin-1 dampens pulmonary inflammation during acute lung injury. Am J Respir Crit Care Med 181:815-824.
22. Navankasattusas S, Whitehead KJ, Suli A, Sorensen LK, Lim AH, Zhao J, Park KW, Wythe JD, Thomas KR, Chien CB, Li DY. (2008). The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 135:659-667.
23. NCCN. (2011). NCCN clinical practice guidelines in oncology (NCCN Guidelines™). Version 2. Gastric Cancer, p 62.
24. Nguyen A, Cai H. (2006). Netrin-1 induces angiogenesis via a DCCdependent ERK1/2-eNOS feed-forward mechanism. Proc Natl Acad Sci USA 103:6530-6535.
25. Paradisi A, Maisse C, Coissieux MM, Gadot N, Lépinasse F, Delloye-Bourgeois C, Delcros JG, Svrcek M, Neufert C, Fléjou JF, Scoazec JY, Mehlen P. (2009). Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci USA 106:17146-17151.
26. Ramesh G, Berg A, Jayakumar C. (2011). Plasma netrin-1 is a diagnostic biomarker of human cancers. Biomarkers 16:172-180.
27. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK. (2009). Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 10:195-202.
28. Wang W, Reeves WB, Ramesh G. (2008). Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol 294:F739-F747.
29. Wilson BD, Ii M, Park KW, Suli A, Sorensen LK, Larrieu-Lahargue F, Urness LD, Suh W, Asai J, Kock GA, Thorne T, Silver M, Thomas KR, Chien CB, Losordo DW, Li DY. (2006). Netrins promote developmental and therapeutic angiogenesis. Science 313:640-644.